The above chart presents the market trend analysis for opsonin bulk drugs ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 7 transactions, with a transaction quantity of 0 and a transaction weight of 139920.
opsonin bulk drugs ltd. is bangladesh Buyer,
and primarily engages in the import and export business of products such as basic chemical,fcmic chloride,ethyl acetate.
According to the 52wmb.com global trade database, as of 2025-10-29, the company has completed 68 international trades,
with its main trading regions covering china,india,germany etc.
The core products include HS29349990,HS29159000,HS29153100 etc,
often transported via chattogram,port chittagong, port dhaka etc,
and its main trading partners are jubilant ingrevia ltd.,1 jubilant life sciences usa inc.,basf hong kong ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on opsonin bulk drugs ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.